FDA Recall Open, Classified

cobas Influenza A/B & RSV UC (Utility Channel) Qualitative nucleic acid test for use on the cobas 6800/8800 Systems; Material number 09233962190

Recall: Z-1106-2023 · Initiated December 21, 2022

Recall

Recall Number
Z-1106-2023
Event Number
91482
Firm
Roche Molecular Systems, Inc.
FEI Number
2243471
Product Code
QLT
Status
Open, Classified
Root Cause
Device Design
Initiated
December 21, 2022
Posted
February 7, 2023
Address
1080 Us Highway 202 S, Branchburg, NJ, 08876-3733

Description

cobas Influenza A/B & RSV UC (Utility Channel) Qualitative nucleic acid test for use on the cobas 6800/8800 Systems; Material number 09233962190

Reason

The firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.

Action

On December 22, 2022, Roche posted the Urgent Medical Device Correction (UMDC) to its website (dialog.roche.com). On December 27, 2022, the firm also sent UMDC letters to affected customers. Consignees were instructed to monitor for negative influenza A results that are inconsistent with clinical presentation and/or other clinical and epidemiological information. Authorized or licensed Influenza NAATs are available for confirmation if clinically indicated for at-risk patients. Additionally, consignees are reminded to review the tests Instructions for Use, specifically the Intended Use Statements and Procedural Limitations sections, which provide guidance on how negative results should be utilized and mutations within the target regions of the tests can impact detection, respectively. Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions about this recall

Distribution

Domestic distribution nationwide. Foreign distribution worldwide.

Quantity

727 kits OUS only